 | | | | Mexico reported 2,894 new confirmed cases of COVID-19 and 216 more fatalities, bringing the total to 2,426,822 infections and 228,362 deaths, according to Health Ministry data released on Thursday. | | | | | | The United States had administered 297,720,928 doses of COVID-19 vaccines in the country and distributed 368,375,195 doses as of Thursday morning, the U.S. Centers for Disease Control and Prevention said. | | | | | | Democratic Republic of Congo is facing a third wave of coronavirus infections, with its epicentre in the capital, Kinshasa, one of Africa's most-populous cities, Health Minister Jean-Jacques Mbungani said on Thursday. | | | | | | The United States on Thursday told India about its plans to make COVID-19 vaccines available to other countries, including the South Asian nation, Prime Minister Narendra Modi's office said. | | | | | | Chile's health ministry said Thursday it would raise the minimum age of men approved to receive the AstraZeneca (AZN.L) coronavirus vaccine to 45, from 18, until authorities complete an investigation into a young man who had a blood clot after his first shot. | | | | | | Britain recorded 5,274 new COVID-19 cases on Thursday, its highest daily total since March 26, Public Health England said, adding there had been 18 more deaths within 28 days of a positive test. | | | | | | Guatemala's President Alejandro Giammattei said on Thursday that the United States will supply half a million COVID-19 doses to the Central American country. | | | | | | The White House laid out a plan on Thursday for the United States to share 25 million surplus COVID-19 vaccine doses with the world and said it would lift some restrictions to allow other countries to more easily buy U.S.-made supplies for vaccine production. | | | | | | The heads of the International Monetary Fund and World Bank on Thursday urged the Group of Seven advanced economies to release any excess COVID-19 vaccines to developing countries as soon as possible, and called on manufacturers to ramp up production. | | | | | | Men with a deadly form of advanced prostate cancer who failed other treatments survived four months longer after getting an experimental, tumour-targeting radiation therapy from Swiss drugmaker Novartis (NOVN.S), data released on Thursday showed. | | | | | |
